
Depaxil CR Plus 12.5 Tablet
Marketer
Alkem Laboratories Ltd
Salt Composition
Paroxetine (12.5mg) + Clonazepam (0.5mg)
Overview Depaxil CR Plus 12.5 Tablet
Deprexis CR Plus 12.5mg tablets are a prescription medication for depression. This combination drug elevates brain neurotransmitters, thereby improving mood and reducing excessive neuronal activity. Deprexis CR Plus 12.5mg can be ingested with or without food, consistently at the same time daily for optimal blood levels. Follow your physician's prescribed dosage and duration; this medication has addictive potential. Avoid missed doses, but if one is missed, take it immediately upon recall. Complete the entire course, even with symptom improvement. Sudden cessation may trigger withdrawal. Common side effects include nausea, vomiting, confusion, memory problems, reduced libido, delayed ejaculation, dizziness, and drowsiness. Avoid driving or tasks requiring concentration until the drug's effects are known. Report any unusual mood changes or depressive episodes, including suicidal ideation, to your doctor. Caution is advised in patients with liver conditions. Disclose all other medications to your doctor, as interactions may reduce efficacy or alter the drug's action. Inform your doctor if pregnant, planning pregnancy, or breastfeeding.
Uses of Depaxil CR Plus 12.5 Tablet
Clinical depression
Major Benefits of Depaxil CR Plus 12.5 Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Depaxil CR Plus 12.5 Tablet whole; avoid chewing, crushing, or breaking it. While it can be taken with or without food, consistent timing is recommended for optimal results.
Common Side effects of Depaxil CR Plus 12.5 Tablet:
- Nausea
- Vomiting
- Diarrhea
- Confusion
- Memory impairment
- Uncoordinated body movements
- Drowsiness
- Tiredness
- Anorgasmia (decreased orgasm)
- Low sexual desire
- Delayed ejaculation
How to use Depaxil CR Plus 12.5 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Depaxil CR Plus 12.5 Tablets. These tablets should be swallowed whole; avoid chewing, crushing, or breaking them. While Depaxil CR Plus 12.5 Tablets can be taken with or without food, consistent timing is recommended.
How Depaxil CR Plus 12.5 Tablet works:
Extended-release Depaxil Plus tablets, 12.5mg strength, contain a dual-medication formulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Depaxil CR Plus 12.5 Tablet with alcohol is not advisable due to safety concerns.
PregnancyUNSAFE
Venlafaxine extended-release 12.5 mg tablets pose a substantial risk during pregnancy. Pregnant women should consult their physician; animal and human studies indicate significant adverse effects on fetal development.
Breast feedingCONSULT YOUR DOCTOR
The use of Depaxil CR Plus 12.5mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by side effects associated with Depaxil CR Plus 12.5 mg tablets.
KidneySAFE IF PRESCRIBED
Employing Depaxil CR Plus 12.5 mg tablets in patients with kidney disease appears to present a low risk. Current evidence indicates dose modification may be unnecessary; however, physician consultation is advised. Patients with end-stage renal disease may experience pronounced somnolence with Depaxil CR Plus 12.5 mg tablet use.
LiverCAUTION
Individuals with hepatic impairment should use Depaxil CR Plus 12.5 mg tablets cautiously. Dosage modification may be necessary. Physician consultation is recommended.
What if you forget to take Depaxil CR Plus 12.5 Tablet :
Should you forget a Depaxil CR Plus 12.5 Tablet dose, take it immediately. If, however, your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Depaxil CR Plus 12.5 Tablet
| Label | Value |
|---|---|
| Developing Habits | Affirmative. |
| Treatment Category | Neuroscience Central Nervous System |
